GLP-1 Users Develop Obsession with Perfume

A growing number of individuals using GLP-1 weight loss medications are experiencing an intense new interest in fragrances, a phenomenon informally dubbed "Ozempic smell." This unexpected side effect has led many users to amass extensive perfume collections, with a particular fondness for sweet, gourmand scents like vanilla and cinnamon. One teacher, Katie, who began taking Zepbound in March 2024, saw her interest in fragrance skyrocket from mild to obsessive, expanding her collection from a few designer bottles to over 50 niche fragrances, costing her approximately $3,000.

Experts propose that GLP-1 drugs may be influencing the brain's olfactory pleasure centers, making users more sensitive to pleasant scents, including perfumes, without triggering food cravings. This heightened sensitivity is linked to the drugs' interaction with GLP-1 receptors on olfactory bulb neurons and their impact on brain cells that process nausea and other internal states. While not a formally recognized trial side effect, this unusual impact on scent perception appears to be a peculiar consequence for some individuals on these popular weight loss treatments.